Moser Wealth Advisors’s Cardiff Oncology CRDF Stock Holding History

Moser Wealth Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.54K	Hold	806	–	–	﹤0.01%	183
2025 Q1	$2.53K	Hold	806	–	–	﹤0.01%	148
2024 Q4	$3.5K	Hold	806	–	–	﹤0.01%	130
2024 Q3	$2.15K	Hold	806	–	–	﹤0.01%	133
2024 Q2	$1.79K	Hold	806	–	–	﹤0.01%	141
2024 Q1	$4.3K	Hold	806	–	–	﹤0.01%	132
2023 Q4	$1.19K	Hold	806	–	–	﹤0.01%	137
2023 Q3	$1.12K	Buy	+806	New	+$1.36K	﹤0.01%	132

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Moser Wealth Advisors's CRDF Position: Q2 2025 in Review

Moser Wealth Advisors held its Cardiff Oncology (CRDF) position steady in Q2 2025 at 806 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #183.

Moser Wealth Advisors first reported a position in CRDF in Q3 2023 and has held it in 8 quarters since. The position peaked at $4.3K in Q1 2024. 114 funds tracked by Wall St. Rank hold CRDF as of Q2 2025.

Moser Wealth Advisors held 806 shares of Cardiff Oncology worth $2.54K as of Q2 2025.
Moser Wealth Advisors left its Cardiff Oncology share count unchanged in Q2 2025.
Cardiff Oncology made up ﹤0.01% of Moser Wealth Advisors's portfolio in Q2 2025, its #183 holding.
Moser Wealth Advisors first reported a position in Cardiff Oncology in Q3 2023 and has held it in 8 quarters since.
Moser Wealth Advisors's Cardiff Oncology position peaked at $4.3K in Q1 2024.
114 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2025.

Based on Moser Wealth Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.